Next Article in Journal
Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model
Next Article in Special Issue
Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective
Previous Article in Journal
Dynamics of SARS-CoV-2 IgG in Nursing Home Residents in Belgium Throughout Three BNT162b2 Vaccination Rounds: 19-Month Follow-Up
Previous Article in Special Issue
Rotavirus Vaccine Administration in Preterm and Medically Fragile Infants Admitted to Neonatal Intensive Care Units: Second Phase Enrollments and Final Results of a Multicenter Observational Study Conducted in Sicily, Italy
 
 
Article

Article Versions Notes

Vaccines 2025, 13(4), 410; https://doi.org/10.3390/vaccines13040410
Action Date Notes Link
article xml file uploaded 15 April 2025 10:01 CEST Original file -
article xml uploaded. 15 April 2025 10:01 CEST Update -
article pdf uploaded. 15 April 2025 10:01 CEST Version of Record -
article html file updated 15 April 2025 10:03 CEST Original file -
article xml file uploaded 15 April 2025 15:24 CEST Update -
article xml uploaded. 15 April 2025 15:24 CEST Update https://www.mdpi.com/2076-393X/13/4/410/xml
article pdf uploaded. 15 April 2025 15:24 CEST Updated version of record https://www.mdpi.com/2076-393X/13/4/410/pdf
article html file updated 15 April 2025 15:26 CEST Update https://www.mdpi.com/2076-393X/13/4/410/html
Back to TopTop